Aptus Pharma approval is a significant step as BSE grants in-principle backing for ₹44.78 crore preferential issue.
Tag: pharma investment
Japan Sleep Drug Approval: A Smart Move for Viatris Investors
Japan sleep drug approval could significantly impact Viatris’ investment case positively.
